Logo image of GYRE

GYRE THERAPEUTICS INC (GYRE) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:GYRE - US4037831033 - Common Stock

7.85 USD
-0.2 (-2.48%)
Last: 1/23/2026, 8:00:33 PM
7.85 USD
0 (0%)
After Hours: 1/23/2026, 8:00:33 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
GYRE revenue by date.GYRE revenue by date.
790K
-89.24%
113.45M
14,260.76%
105.757M
-6.78%
118.01M
11.59%
149.06M
26.31%
150.25M
0.80%
451.96M
200.81%
278.36M
-38.41%
324.56M
16.60%
403.92M
24.45%
406.98M
0.76%
486.54M
19.55%
EBITDA
YoY % growth
GYRE ebitda by date.GYRE ebitda by date.
-29.21M
66.65%
20.287M
169.45%
17.778M
-12.37%
20.808M
17.04%
16.524M
-20.59%
918K
-94.44%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
GYRE ebit by date.GYRE ebit by date.
-29.41M
66.54%
19.213M
165.33%
16.229M
-15.53%
18.207M
12.19%
9.69M
-46.78%
12.954M
33.68%
281.42M
2,072.46%
67.014M
-76.19%
98.226M
46.58%
117.3M
19.42%
96.9M
-17.39%
155.04M
60.00%
Operating Margin
GYRE operating margin by date.GYRE operating margin by date.
-3,722.78%16.94%15.35%15.43%6.50%8.62%62.27%24.07%30.26%29.04%23.81%31.87%
EPS
YoY % growth
GYRE eps by date.GYRE eps by date.
N/A
132.70%
N/A
-117.39%
N/A
112.87%
0.19
-40.64%
0.19
1.82%
0.04
-78.57%
2.32
5,575.00%
0.68
-70.48%
0.94
37.31%
1.55
65.22%
1.43
-7.89%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.06
5,717.10%
0.08
172.00%
0.06
206.00%
0.04
-49.00%
0.05
-21.05%
Revenue
Q2Q % growth
37.029M
32.85%
35.292M
60.00%
38.046M
42.12%
41.004M
34.16%
45.084M
21.75%
EBITDA
Q2Q % growth
9.18M
315.01%
N/AN/AN/AN/A
EBIT
Q2Q % growth
4.08M
515.38%
4.998M
119.89%
2.958M
36.25%
-4.998M
-172.17%
N/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.08 0.030.05194.08%
Q2 2025
Q2Q % growth
0.02 0.03-0.01-34.64%
Q1 2025
Q2Q % growth
0.03 0.030.00-1.96%
Q4 2024
Q2Q % growth
0.00
99.81%
0.04-0.04-102.82%
Q4 2023
Q2Q % growth

61.90%
-0.61%
Q3 2023
Q2Q % growth
-1.05
56.25%
-0.77-0.29-37.25%
Q2 2023
Q2Q % growth
-1.05
61.11%
-1.070.021.96%
Q1 2023
Q2Q % growth
0.15
102.17%
-1.071.22114.01%
Q4 2022
Q2Q % growth

83.27%
-1.61%
Q3 2022
Q2Q % growth
-2.40
80.00%
-1.53-0.87-56.86%
Q2 2022
Q2Q % growth
-2.70
71.88%
-3.751.0527.97%
Q1 2022
Q2Q % growth
-6.90
41.77%
-6.78-0.12-1.73%
Q4 2021
Q2Q % growth
-9.60
25.58%
-8.99-0.61-6.80%
Q3 2021
Q2Q % growth
-12.00
-9.59%
-10.10-1.90-18.84%
Q2 2021
Q2Q % growth
-9.60
33.33%
-10.631.039.72%
Q1 2021
Q2Q % growth
-11.85
-182.14%
-8.84-3.01-34.11%
Q4 2020
Q2Q % growth
-12.90 -13.200.302.24%
Q3 2020
Q2Q % growth
-10.95 -12.341.3911.28%
Q2 2020
Q2Q % growth
-14.40 -13.20-1.20-9.12%
Q1 2020
Q2Q % growth
-4.20 -5.581.3824.79%
GYRE Yearly EPS VS EstimatesGYRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -100 -200 -300
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
30.564M
19.92%
33.589M-3.025M-9.01%
Q2 2025
Q2Q % growth
26.771M
6.13%
31.416M-4.645M-14.79%
Q1 2025
Q2Q % growth
22.058M
-18.82%
28.968M-6.91M-23.85%
Q4 2024
Q2Q % growth
27.872M
-75.43%
23.97M3.902M16.28%
Q1 2023
Q2Q % growth

-100.00%
%
Q4 2022
Q2Q % growth

-100.00%
%
Q3 2022
Q2Q % growth

-100.00%
%
Q2 2022
Q2Q % growth

-100.00%
%
Q1 2022
Q2Q % growth
790K
-46.26%
790K%
Q4 2021
Q2Q % growth
2.44M
20.20%
170.003K2.27M1,335.27%
Q3 2021
Q2Q % growth
2.3M
158.43%
688.5K1.612M234.06%
Q2 2021
Q2Q % growth
1.13M
-31.93%
339.997K790.003K232.36%
Q1 2021
Q2Q % growth
1.47M
-91.02%
816K654K80.15%
Q4 2020
Q2Q % growth
2.03M 51K1.979M3,880.39%
Q3 2020
Q2Q % growth
890K 1.071M-181K-16.90%
Q2 2020
Q2Q % growth
1.66M 306K1.354M442.48%
Q1 2020
Q2Q % growth
16.37M 8.109M8.261M101.87%
GYRE Yearly Revenue VS EstimatesGYRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS18.75% 72.7% 22.22% 77.42%
Revenue0% -3.86% 0% -3.18%